id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6554-0002,FDA,FDA-2017-D-6554,Refuse to File: NDA and BLA Submissions to CDER Guidance for Industry,Other,Guidance,2017-12-13T05:00:00Z,2017,12,2017-12-13T05:00:00Z,2018-02-13T04:59:59Z,2024-11-07T01:13:45Z,,1,0,0900006482d03da6
FDA-2017-D-6554-0001,FDA,FDA-2017-D-6554,Guidance: Refuse to File-New Drug Application and Biologics License Application Submissions to the Center for Drug Evaluation and Research,Notice,Guidance,2017-12-13T05:00:00Z,2017,12,2017-12-13T05:00:00Z,2018-02-13T04:59:59Z,2017-12-13T14:40:07Z,2017-26791,0,0,0900006482d01c53